Over-the-Counter Human Drugs; Labeling Requirements

Forms and Documents

Forms and supporting documents for this ICR

Document	Type	Status	Availability
Response to PCPC PRA comment (12-23-10) #3.doc	Supplementary Document	Uploaded 2010-12-27	Available
Supporting Statement A (12-23-10) #3.doc	Supporting Statement A	Uploaded 2010-12-27	Repair queued

IC Document Collections

Information collection document groups

IC ID	Collection	Type	Status	Form
5943	Over-the-Counter Human Drugs; Labeling Requirements		Modified

ICR Details

OMB Control No: 0910-0340	ICR Reference No: 201008-0910-009
Status: Historical Active	Previous ICR Reference No: 200504-0910-004
Agency/Subagency: HHS/FDA	Agency Tracking No:
Title: Over-the-Counter Human Drugs; Labeling Requirements
Type of Information Collection: Reinstatement with change of a previously approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved with change	Conclusion Date: 01/31/2011
	Date Received in OIRA: 08/26/2010
Terms of Clearance:

table that charts list comparision

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	01/31/2014	36 Months From Approved
Responses	5,650	0	0
Time Burden (Hours)	14,303	0	0
Cost Burden (Dollars)	3,663,000	0	0

---

Abstract: The purpose of this collection is to establish a standardized format for the labeling of all OTC drug products so that the labeling will be easier to read and have consistent text in like situations. Variability in the design, format, and placement of required OTC drug product labeling information may make it difficult for consumers to both find and read safety information. For consumers this information must be clear and precise and clearly understood.

---

Authorizing Statute(s): US Code: 21 USC 201, 502, 503, 505, and 701 Name of Law: Federal Food, Drug, and Cosmetics Act
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	75 FR 31448	06/03/2010
30-day Notice:	Federal Register Citation:	Citation Date:
	75 FR 49495	08/13/2010
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

table that charts list of burden

IC Title	Form No.	Form Name
Over-the-Counter Human Drugs; Labeling Requirements

---

ICR Summary of Burden

table that charts list of burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	5,650	0	0	0	5,650	0
Annual Time Burden (Hours)	14,303	0	0	0	14,303	0
Annual Cost Burden (Dollars)	3,663,000	0	0	0	3,663,000	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement:

---

Annual Cost to Federal Government: $0

Does this IC contain surveys, censuses, or employ statistical methods? No

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 08/26/2010

---